{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:45:46Z","timestamp":1775846746093,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jaut.2015.05.011","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T05:30:13Z","timestamp":1434691813000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis"],"prefix":"10.1016","volume":"62","author":[{"given":"Chang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashid M.","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Egwuagu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.05.011_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jaut.2015.05.011_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/08830180212067","article-title":"Bench to bedside: new approaches to the immunotherapy of uveitic disease","volume":"21","author":"Nussenblatt","year":"2002","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib3","first-page":"1872","article-title":"Understanding autoimmune uveitis through animal models. The Friedenwald Lecture","volume":"52","author":"Caspi","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2015.05.011_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib5","doi-asserted-by":"crossref","first-page":"36012","DOI":"10.1074\/jbc.M112.390625","article-title":"Novel IL27p28\/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1\/Th17 cells and promoting expansion of regulatory T cells","volume":"287","author":"Wang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.05.011_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib8","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib11","first-page":"e24134","article-title":"Therapeutic targeting of STAT pathways in CNS autoimmune diseases","volume":"2","author":"Egwuagu","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.jaut.2015.05.011_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2015.05.011_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"Kubo","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm896","article-title":"SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses","volume":"9","author":"Seki","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib16","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1167\/iovs.11-7688","article-title":"Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation","volume":"52","author":"Yu","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2015.05.011_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm1269","article-title":"Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis","volume":"11","author":"Jo","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2015.05.011_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2010.10.018","article-title":"The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis","volume":"232","author":"Jager","year":"2011","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2005.07.021","article-title":"Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins","volume":"168","author":"Takase","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib20","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1167\/iovs.06-1099","article-title":"Panretinal, high-resolution color photography of the mouse fundus","volume":"48","author":"Paques","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2015.05.011_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2008.06.012","article-title":"A\u00a0clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images","volume":"87","author":"Xu","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2015.05.011_bib22","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.4049\/jimmunol.172.12.7510","article-title":"Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function","volume":"172","author":"Flowers","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib23","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.4049\/jimmunol.178.8.5058","article-title":"Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist","volume":"178","author":"Waiboci","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","article-title":"A\u00a0new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens","volume":"140","author":"Caspi","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib25","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.4049\/jimmunol.159.7.3109","article-title":"Thymic expression of autoantigens correlates with resistance to autoimmune disease","volume":"159","author":"Egwuagu","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib26","doi-asserted-by":"crossref","first-page":"e72161","DOI":"10.1371\/journal.pone.0072161","article-title":"Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.05.011_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/brain\/awl273","article-title":"Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia","volume":"130","author":"Li","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2015.05.011_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2013.11.022","article-title":"The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation","volume":"40","author":"Yoshida","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.05.011_bib29","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ni1372","article-title":"Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice","volume":"7","author":"van Loo","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.05.011_bib30","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1128\/MCB.00980-14","article-title":"PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation","volume":"34","author":"Meares","year":"2014","journal-title":"Mol. Cell. Biol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:11:32Z","timestamp":1760256692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"alternative-id":["S0896841115000827"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.05.011","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}